title: Idarucizumab approved for reversal of anticoagulant effects of dabigatran.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects*; D000069604:Dabigatran / Q000009:adverse effects*; D017277:Drug Approval; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; C000594745:idarucizumab; D000069604:Dabigatran